JNJ News 105.65 06/27/2014 05:08:12 Johnson & Johnson (JNJ)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Johnson & Johnson (JNJ) 105.65 $JNJ

US Wound Care Market Trends Forecast Through 2019
M2 - 5 mins ago
Research and Markets (http://www.researchandmarkets.com/research/c98bcn/us_wound_care) has announced the addition of the "US Wound Care Market Trends Forecast Through 2019" report to their offering. The Market Intelligence report provides critical market data for US wound care market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as traditional wound care, wound dressings, negative pressure wound therapy (NPWT), wound closure devices, ostomy bags, compression therapy. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 US Market for Wound Care (2006-2019) 5 US Market for Traditional Wound Care (2006-2019) 6 US Market for Wound Dressings (2006-2019) 7 US Market for Negative Pressure Wound Therapy (NPWT) (2006-2019) 8 US Market for Wound Closure Devices (2006-2019) 9 US Market for Ostomy (2006-2019) 10 US Market for Compression Therapy (2006-2019) 11 Recent Events and Developments 12 Appendix Companies Mentioned: - 3M Health Care - Advanced Medical Solutions Group Plc - B. Braun Melsungen AG - Baxter International Inc. - BSN medical GmbH - Coloplast A/S - ConvaTec - Covidien Ltd. - Ethicon, Inc. - Hartmann Group - Hollister Incorporated - Johnson & Johnson - Kinetic Concepts, Inc. - Nycomed International Management GmbH - Smith & Nephew Plc For more information visit http://www.researchandmarkets.com/research/c9...wound_care

Final Glance: Medical Devices companies
AP - Thu Jun 26, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Thu Jun 26, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

How America's 5 Biggest Pharma Stocks Stack up
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Thu Jun 26, 4:00PM CDT
For new health care investors particularly, America's five largest pharma stocks ( Johnson & Johnson  ,  Pfizer  ,  Merck  ,  Bristol-Myers Squibb  , and  Eli Lilly  ) are a good place to start. So, how do they stack up? in the video below,...

Midday Glance: Pharmaceuticals companies
AP - Thu Jun 26, 12:21PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:

Midday Glance: Medical Devices companies
AP - Thu Jun 26, 12:21PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:

Early Glance: Medical Devices companies
AP - Thu Jun 26, 9:38AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:

Early Glance: Pharmaceuticals companies
AP - Thu Jun 26, 9:38AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Stock Market News for June 26, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 9:06AM CDT
Gains in media stocks helped benchmarks shrug off weak economic data and settle in the green

Male Toiletries Market in Europe 2014-2018
M2 - Thu Jun 26, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s4csft/male_toiletries) has announced the addition of the "Male Toiletries Market in Europe 2014-2018" report to their offering. Male toiletries include products that are used every day by male consumers before, during, and after shaving. There are two types of shaving: dry shaving and wet shaving. The market primarily includes retail sales of razors, blades, shavers, stylers, creams, gels, lotions, oils, and skin care products used for the entire shaving process. The Male Toiletries market in Europe can be categorized into three segments: shaving Tools/razors, pre-shave products, and aftershave products. These are product categories used by male consumers in Europe for personal grooming and skincare. The report, the Male Toiletries Market in Europe 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers two geographic regions, EU5 and Others; it also covers the Male Toiletries market in Europe landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors - Beiersdorf AG - Energizer Holdings Inc. - Koninklijke Philips NV - Procter & Gamble Co. Other Prominent Vendors - Avon Products Inc. - Colgate-Palmolive Co. - Coty Inc. - Dalli-Werke M?urer & Wirtz GmbH & Co. KG - Est?e Lauder Co. Inc. - Henkel AG & Company KGaA - Johnson & Johnson Inc. - Lancaster Group - L'Oreal SA - Mirato Nuova SpA - PZ Cussons plc - Soci?t? Bic SA - The Boots Co. plc - Unilever Group Key Market Drivers/Challenges/Trends - Increased Beauty and Skin Consciousness among Male Consumers. - Impact of Economic Uncertainties. - Emergence of Natural and Organic Products. Key Questions Answered in this Report - What will the market size be in 2018 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? For more information visit http://www.researchandmarkets.com/research/s4...toiletries

Facial Care Market in the US 2014-2018
M2 - Thu Jun 26, 8:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s3n37v/facial_care) has announced the addition of the "Facial Care Market in the US 2014-2018" report to their offering. One of the main drivers is the growing aging population in the country. An aging population has more need for anti-aging and age-defying facial care products that promise a youthful, healthy, and radiant look. Facial care products have been developed specifically for the maintenance and enhancement of the face. They constitute the largest category in the Skin Care market and include product varieties such as facial moisturizers, cleansers, age-defying products, gels, toners, and scrubs. They are usually made of synthetic or natural ingredients combined with additional substances such as carrier agents, preservatives, emulsifiers, and surfactants. The Facial Care market in the US can be divided into five segments: Age-defying Products, Facial Moisturizers, Facial Cleansers, Face Cleaning Wipes and Tissues, and Other Face Care Products. These provide different facial care benefits to consumers. The Facial Care market in the US has also been segmented based on the type of distribution channel. The report, the Facial Care Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Facial Care market in the US market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors - Johnson & Johnson Inc. - L'Or?al SA - Procter & Gamble Co. - Unilever Group Other Prominent Vendors - Aubrey Organics Inc. - Avon Products Inc. - Beiersdorf AG - Carma Laboratories Inc. - Chanel USA - Colgate-Palmolive Co. - Elizabeth Arden Inc. - Est?e Lauder Co. Inc. - Galderma SA - Giovanni Cosmetics Inc. - Guthy-Renker Corp. - Hain Celestial Group Inc. - Henkel AG & Co KGaA - Kao Corp. - Kimberly-Clark Corp. - Limited Brands Inc. - Oriflame Cosmetics SA - Revlon Inc. - Shiseido Co. - The Clorox Co. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Distribution Channel - Market Segmentation by Product - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/s3...acial_care

Advanced Wound Care Markets Worldwide
M2 - Thu Jun 26, 6:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/crcd5q/advanced_wound) has announced the addition of the "Advanced Wound Care Markets Worldwide" report to their offering. Advanced Wound Care Markets The wound care industry is an incredibly diverse and highly competitive arena that is ever-changing. Kalorama Information feels that the market will continue to expand over the long term due to an aging population, longer life expectancies, and an increasing number of sicker patients across all care settings. This report, Advanced Wound Care Markets, provides breakouts of the market by category, including the following: - Skin Ulcers (Management, Moist Dressing, Negative Pressure Wound Therapy, Biological Dressings, Pressure Relief) - Burns Wound Care Market (Anti-Infectives, Management, Moist Dressing, Biological Dressings, Pressure Relief) - Surgical and Trauma Wounds (Wound Closure, Anti-Infectives, Moist Dressing, Biological Dressing, Miscellaneous Surgical and Trauma Wound Treatments) Wound Care Clinics The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 100 face to face, telephone and email interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections. - 3M Health Care - ABL Medical, LLC - ACELL, INC - Alliqua Biomedical, Inc - Amniox Medical - Angelini Pharma, Inc - Argentum Medical, LLC - ArjoHuntleigh - Arobella Medical, LLC - Baxter Bioscience - B. Braun/Aesculap, Inc. - BSN medical - Celleration - Coloplast A/S - ConvaTec, Ltd. - Covidien, Ltd - CryoLife, Inc. - Curaline, Inc - Derma Sciences - DeRoyal Industries - EHOB, Inc - Ethicon, Inc - GlaxoSmithKline Plc - Hartmann Group - Hill-Rom Company, Inc. - Hollister Wound Care LLC - Integra Life Sciences - Johnson & Johnson - Kinetic Concepts, Inc. (KCI) - LifeBond Ltd - Lohmann and Rauscher GmbH - Marine Polymer Technologies, Inc. - Medline Industries - MiMedx - Molnlycke HealthCare - MPM Medical, Inc - Oculus Innovative Sciences, Inc - Organogenesis, Inc - Osiris Therapeutics, Inc - Pfizer, Inc. - Shire Plc - Smith & Nephew, Plc - Soluble Systems, LLC - Southwest Technologies - Spiracur, Inc - SteadMed Medical - Stryker Corp For more information visit http://www.researchandmarkets.com/research/cr...nced_wound

Severe Psoriasis - Pipeline Review, H1 2014
M2 - Thu Jun 26, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/87xfgx/severe_psoriasis) has announced the addition of the "Severe Psoriasis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Severe Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Severe Psoriasis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Severe Psoriasis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Severe Psoriasis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Almirall - Amgen. - ApoPharma - Boehringer Ingelheim - Eli Lilly and Company - Idera - Johnson & Johnson - Syntrix Biosystems - Vascular Biogenics For more information visit http://www.researchandmarkets.com/research/87..._psoriasis

Watch for Johnson & Johnson to Potentially Pullback After Gaining 1.12% Yesterday
Comtex SmarTrend(R) - Wed Jun 25, 3:48PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.23 to a high of $105.87. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $105.48 on volume of 6.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Patent Infringement War Continues Between Covidien and J&J Unit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:15PM CDT
The lawsuit alleges that Ethicon's latest ultrasonic surgical product ??? Harmonic ACE+7 ??? infringes three Covidien plc (COV) patents.

A Smart Move for Endo International?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Jun 25, 12:01PM CDT
It's hard to find fault with Endo International PLC . Management has done a great job of unwinding the mistakes of past management and has pursued an aggressive growth-by-M&A strategy that has the company well-positioned for the future and...

CARE WITH PRIDE(TM) On Target To Deliver More Than $500K to LGBT Charities
PR Newswire - Wed Jun 25, 8:30AM CDT
Johnson & Johnson's corporate-wide anti-bullying and LGBT equality initiative is expanding as it kicks off its third year in June. Since 2012, donations raised through CARE WITH PRIDE(TM) have supported PFLAG's anti-bullying efforts and this year, The Trevor Project and Family Equality Council are newly added beneficiaries. By the end of 2014, it is projected that CARE WITH PRIDE (TM) will have raised more than $500K for our LGBT charitable partners since the program's inception in 2012.

Arteriosclerosis - Pipeline Review, H1 2014
M2 - Wed Jun 25, 4:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/64g45x/arteriosclerosis) has announced the addition of the "Arteriosclerosis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Arteriosclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arteriosclerosis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Arteriosclerosis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Arteriosclerosis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Companies Mentioned: - AnGes MG - Angelini - CytoTools - ECI - Johnson & Johnson - Kowa Company - KunWha Pharmaceutical - LTT Bio-Pharma - Nippon Shinyaku For more information visit http://www.researchandmarkets.com/research/64...osclerosis
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 63

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 9

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 84

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 89

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 119

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 53

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 156

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 179

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 132

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading

Top 5 Most Recently Viewed Articles

Social Media Buzz Powers Hainan's Travel Boom

Updated Category News Views 205

Social Media Buzz Powers Hainan's Travel Boom This year marks a remarkable shift in Hainan's tourism, driven by the advent of visa-free travel access for international visitors. As the beautiful island in southern China opens its doors wider, a surge in travelers, especially travel bloggers from around the globe, is noticeable. Influencers from diverse backgrounds,...

Continue Reading
Kodiak Sciences Reports Q3 2025 Financial Milestones and Updates

Updated Category News Views 375

Kodiak Sciences Reports Q3 2025 Financial Milestones and Updates Kodiak Sciences Inc. (Nasdaq: KOD) has recently shared significant business highlights along with financial results for the third quarter of 2025. This biotechnology company is making strides in the field of retinal medicine. 'We are witnessing a period marked by sustained momentum,' expressed Victor...

Continue Reading
Vaisala Initiates Share Repurchase Program to Enhance Incentives

Updated Category News Views 193

Vaisala’s Strategy for Share Repurchases Vaisala Corporation is embarking on an important journey to repurchase its own shares as part of a broader incentive plan. This strategic decision follows the authorization granted by the Annual General Meeting, reflecting the company's commitment to fostering a rewarding environment for its employees. As a key player in climate...

Continue Reading
Investigating Customer Bancorp, Inc. Losses: Understand Your Rights

Updated Category News Views 92

Exploring Customers Bancorp, Inc.'s Recent Challenges Customers Bancorp, Inc., identified by the ticker CUBI, is dealing with significant accusations regarding the truthfulness of the business information it has shared with the public. The Rosen Law Firm, a respected advocate for investor rights, is currently looking into securities claims tied to these allegations. If...

Continue Reading
Allurity and Onevinn: Transforming Cybersecurity Together

Updated Category News Views 374

Allurity Expands its Cybersecurity Portfolio with Onevinn Acquisition Allurity, a prominent European provider of cybersecurity services, has exciting news to share. The company has taken a significant step forward by acquiring Onevinn, a Swedish company renowned for its intelligent security and managed services. This move not only showcases Allurity's ambitions but also...

Continue Reading